Skip to main content
NCBI home page
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 1986 Apr;111(2):141–148. doi: 10.1007/BF00400753

Urinary polyamine excretion by tumor-bearing and tumor-free mice exposed to cyclophosphamide, 5-fluorouracil and 6-mercaptopurine

Hans Osswald 1,2, Richard Herrmann 1,2, G R N Jones 1,2, Dagmar Kitta 1,2, Werner Kunz 1,2,✉
PMCID: PMC12253886  PMID: 3700458

Abstract

The effects of cytostatic treatment on urinary polyamine excretion have been investigated in tumor-bearing (either Ehrlich carcinoma of S 180 sarcoma) and in tumor-free mice. The animals were exposed to single or multiple treatment with various doses of cyclophosphamide, 5-fluorouracil, or 6-mercaptopurine. Treatment invariably enhanced polyamine excretion dependent on dose and effectiveness of the cytostatic drug. The most pronounced increases were observed in the excretion of spermine and putrescine, with peak excretion usually occurring after 1–2 and 3–4 days, respectively. The urinary excretion of spermidine was relatively modest in untreated mice, but the increases observed following drug treatment were high in proportion.

Significant differences in urinary polyamine excretion were observed between tumor-free and tumor-bearing animals following treatment with all cytostatic agents. Peak values were invariably higher in tumor-bearing mice even in those with small, barely detectable tumors.

After discontinuation of treatment polyamine excretion returned to normal values and stabilized in groups in which regression predominated, whereas in those groups of animals which showed little or no tumor regression urinary polyamine levels gradually increased again during a 2-week observation period.

Key words: Polyamine excretion, Chemotherapy, Cyclophosphamide, 5-Fluorouracil, 6-mercaptopurine, Ehrlich carcinoma, Sarcoma S 180

References

  1. Abdel-Monem MM, Ohno K, Fortuny IE, Theologides A (1975) Acetylspermidines in human urine. Lancet II:1210 [DOI] [PubMed] [Google Scholar]
  2. Anderson G, Heby O (1972) Polyamine and nucleic acid concentrations in Ehrlich ascites carcinoma cells and liver of tumour bearing mice at various stages of tumour growth. J Natl Cancer Inst 48:165–172 [PubMed] [Google Scholar]
  3. Bachrach U, Ben-Joseph M (1973) Tumor cells polyamines, and polyamine derivates. In: Russell DH (ed) Polyamines in normal and neoplastic growth. Raven Press, New York, pp 15–26 [Google Scholar]
  4. Bassalyk LS, Nemtsova MP, Merabishivili NV, Tevadze TA, Korbukh IA (1982) [Poliaminy V Otsenke Effektivnosti Khimioterapii U Onkologicheskikh Bol'Nykh.]. (Polyamines in the monitoring of the efficacy of chemotherapy in cancer patients) Vestn Akad Med Nauk, SSSR 3:57–61 [PubMed] [Google Scholar]
  5. Bakowski MT, Toseland PA, Wicks JF, Trounce JR (1981) A rapid gas chromatographic method for the determination of plasma polyamines and its application to the prediction of tumour response to chemotherapy. Clin Chim Acta 110:273–286 [DOI] [PubMed] [Google Scholar]
  6. Cohen SS (1977) Conference on polyamines in cancer. Cancer Res 37:939–942 [Google Scholar]
  7. Dreyfuss G, Dvir R, Harell A, Chayen R (1973) Determination of polyamines in urine. Clin Chim Acta 49:65–72 [DOI] [PubMed] [Google Scholar]
  8. Dreyfuss F, Chayen R, Dreyfuss G, Dvir R, Ratan J (1975) Polyamine excretion in the urine of cancer patients. Isr J Med Sci 11:785–795 [PubMed] [Google Scholar]
  9. Durie BGM, Salmon SE, Russell DH (1977) Polyamines as markers of response and disease activity in cancer chemotherapy. Cancer Res 37:2143–2221 [PubMed] [Google Scholar]
  10. Fujita K, Nagatsu T, Maruta K, Ito M, Senba H, Miki K (1976) Urinary putrescine, spermidine and spermine in human blood and solid cancers and in an experimental gastric tumor of rats. Cancer Res 36:1320–1324 [PubMed] [Google Scholar]
  11. Heby O, Sarna GP, Marton LJ, Omine M, Perry S, Russell DH (1973) Polyamine content of AKR leukaemic cells in relation to the cell cycle. Cancer Res 33:2959–2964 [PubMed] [Google Scholar]
  12. Kersten W (1983) Erfolgskontolle durch Polyaminanalyse. Dtsch Med Wochenschr 108:243–245 [DOI] [PubMed] [Google Scholar]
  13. Lipton A, Sheehan LM, Harvey HA (1975) Urinary polyamine levels in patients with gastrointestinal malignancy. Cancer 36:2351–2354 [DOI] [PubMed] [Google Scholar]
  14. Lipton A, Sheehan LM, Kessler GF (1975) Urinary polyamine levels in human cancer. Cancer 35:464–468 [DOI] [PubMed] [Google Scholar]
  15. Marton LJ, Russell DH, Levy CC (1973) Measurement of putrescines, spermidine and spermine in physiological fluids by use of an amino acid analyzer. Clin Chem 19:923–926 [PubMed] [Google Scholar]
  16. Marton LJ, Vaughn JG, Hawk IA, Levy CC, Russell DH (1973) Elevated polyamine levels in serum and urine of cancer patients: detection by a rapid automated technique utilizing and amino acid analyzer. In: Russell DH (ed) Polyamines in normal and neoplastic growth. New York: Raven Press, pp 367–372 [Google Scholar]
  17. Marton LJ, Heby O, Levin VA, Lubich WP, Crafts DC, Wildon CB (1976) The relationship of polyamines in cerebrospinal fluid to the presence of central nervous system tumors. Cancer Res 36:973–977 [PubMed] [Google Scholar]
  18. Milano G, Cassuto JP, Schneider M, Viguier E, Lesbats G, Cambon P, Lalanne CM (1980) Polyamines in lymphomas: their value in disease staging and monitoring of therapy efficiency. Nouv Rev Fr Hematol 22:249–255 [PubMed] [Google Scholar]
  19. Nishioka K, Romsdahl MM (1974) Elevation of putrescine and spermidine in sera of patients with solid tumors. Clin Chim Acta 57:155–161 [DOI] [PubMed] [Google Scholar]
  20. Nissen E, Dettmer R, Fiedler D, Bodammer M (1981) Polyamine und ihre Bedeutung für die Kontrolle der Tumorchemotherapie. Arch Geschwulstforsch 50:336–340 [PubMed] [Google Scholar]
  21. Roth H, Kitta D, Jones GRN, Osswald H, Kunz W (1981) Polyamine responses in a solid transplantable tumor (S 180), in liver, and in urine during endotoxin-induced tumor necrosis in the mouse. Cancer 48:945–950 [DOI] [PubMed] [Google Scholar]
  22. Russell DH (1971) Increased polyamine concentrations in the urine of human cancer patients. Nature 233:144 [DOI] [PubMed] [Google Scholar]
  23. Russel DH (1983) Clinical relevance of polyamines. CRC Crit Rev Clin Lab Sci 18:261–311 [DOI] [PubMed] [Google Scholar]
  24. Russel DH, Durie BGM (1978) Polyamines and the clinical evaluation of patients with cancer. In: Polyamines as biochemical markers of normal and malignant growth. Prog in Cancer Res and Therapy, New York, Raven Press, 8:139–155 [Google Scholar]
  25. Russell DH, Levy CC, Schimpff SC, Hawk IA (1971) Urinary polyamines in cancer patients. Cancer Res 31:1555–1558 [PubMed] [Google Scholar]
  26. Russell DH, Looney WB, Kovacs CJ, Hopkins HA, Marton LJ, LeGendre SM, Morris HP (1974) Polyamide depletion of tumor tissue and subsequent elevation of spermidine in the sera of rats with 3924 A hepatomas after 5-fluorouracil administration. Cancer Res 34:2382–2385 [PubMed] [Google Scholar]
  27. Russell DH, Durie BGM, Almon SE (1975) Polyamines as predictors of success and failure in cancer chemotherapy. Lancet I:797–799 [DOI] [PubMed] [Google Scholar]
  28. Russell DH, Looney WB, Kovacs CJ, Hopkins HA, Dattilo JW, Morris HP (1976) Changes in serum putrescine and spermidine levels following local radiation to hepatoma 3924 A of the rat. Cancer Res 36:420–423 [PubMed] [Google Scholar]
  29. Seiler N, Wiechmann M (1967) Die Mikrobestimmung von Spermin und Spermidin als 1-Dimethylamino-naphthalin-5-sulfonsäure Derivate. Hoppe Seylers Z Physiol Chem 348:1285–1290 [PubMed] [Google Scholar]
  30. Seiler N, Wiechmann M (1970) Analysis of amines as their dans-derivatives. In: Niederwieser A, Pataki G (eds) Problems in thinlayer chromatography and related methods. Ann Arbor Humphrey Science Publishers, Ann Arbor, Michigan, pp 95–144 [Google Scholar]
  31. Seiler N, Koch-Weser B, Knödgen B, Richards W, Tardif C, Bolkenius FN, Schechter P, Tell G, Mamont P, Fozard J, Bachrach U, Grosshans E (1981) The significance of acetylation in the urinary excretion of polyamines. In: Caldarera CM (ed) Advances in polyamine research. Raven Press, New York, pp 197–211 [Google Scholar]
  32. Townsend RM, Banda PW, Marton LJ (1976) Polyamines in malignant melanoma. Cancer 38:2088–2092 [DOI] [PubMed] [Google Scholar]
  33. Waalkes TP, Gehrke CW, Tormey DC, Zumwalt RW, Hueser JN, Kuo KD, Lakings DB, Ahmann DL, Moertel CG (1975) Urinary excretion of polyamines by patients with advanced malignancy. Cancer Chemother Rep 59:1103–1116 [PubMed] [Google Scholar]
  34. Williams-Ashman HG, Coppoc GL, Weber G (1972) Imbalance in ornithine metabolism in hepatomas of different growth rates as expressed in formation of putrescine, spermidine and spermine. Cancer Res 32:1924–1932 [PubMed] [Google Scholar]

Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES